在现行的唑类药物预防的模式背景下，没有通过临床实验资料定义侵袭性曲菌病的突破性治疗。
Management of breakthrough invasive aspergillosis in the context of mould-active azole prophylaxis is not defined by clinical trial data.
在现行的唑类药物预防的模式背景下，没有通过临床实验资料定义侵袭性曲菌病的突破性治疗。
Management of breakthrough invasive aspergillosis in the context of mould-active azole prophylaxis is not defined by clinical trial data.
应用推荐